片语

Receptor tyrosine kinase EphB2酪氨酸蛋白激酶受体EphB

receptor protein tyrosine kinase受体蛋白酪氨酸激酶

non-receptor protein tyrosine kinases非受体酪氨酸激酶

Receptor Tyrosine Kinase受体酪氨酸激酶

receptor protein tyrosine kinases受体酪氨酸激酶

receptor tyrosine phosphataseReceptor tyrosine phosphatase is a type of Enzyme-linked receptor.

Receptor tyrosine kinase pathway受体酪氨酸激酶途经

Receptor Tyrosine Kinase Superfamily受体酪氨酸激酶超家族

英汉例句

• the epidermal growth factor receptor (egfr) family of receptor tyrosine kinases have close connection with the initiation, progression and prognosis of various malignancies.

  表皮生长因子受体（egfr）家族的受体酪氨酸激酶与多种恶性肿瘤的发生、发展及预后等密切相关。

• hnmpa-am3 -the insulin receptor tyrosine kinase inhibitor could block the anti-apoptosis effect of insulin.

  胰岛素受体自身酪氨酸磷酸化抑制剂一一hnmpa一am3可以阻断胰岛素的抗凋亡作用。

• sunitinb is a novel multitargeted receptor tyrosine kinase inhibitor.

  苏尼替尼是一种新型的多靶点酪氨酸激酶抑制剂。

• along with the genetic alterations, sclc overexpresses various cell surface receptors, such as receptor tyrosine kinase (rtks), g-protein-coupled receptors, integrins, and so on.

  伴随着遗传变异，小细胞肺癌还表现出细胞表面受体的过度表达，包括受体酪氨酸激酶、g蛋白耦合受体、整合蛋白及其它受体等。

• all these actions of vegf are mediated by receptor tyrosine kinase, vascular endothelial growth factor receptor (vegfr).

  所有这些作用都是通过血管内皮生长因子受体信号转导通路实现的。

• objective: to establish a method of detecting insulin receptor tyrosine kinase (irtk) activity from erythrocytes.

  目的：建立红细胞胰岛素受体酪氨酸蛋白激酶（irtk）的活性测定法。

• receptor tyrosine kinases (rtk), g protein-coupled receptors (gpcr) and ion channel receptors are main cell surface receptors.

  酪氨酸激酶型受体、g蛋白偶联受体和离子通道型受体是细胞表面三类主要受体。

• human receptor tyrosine kinase, rtks elisa kit; …

  人受体酪氨酸激酶（rtks）试剂盒；

• gefitinib-sensitive mutations of the epidermal growth factor receptor tyrosine kinase domain in chinese patients with non-small cell lung cancer.

  中国的非小细胞肺癌病人中吉非替尼敏感的表皮生长因子受体酪氨酸激酶区域的突变。

• it is thought that extracellular ligand binding to a receptor tyrosine kinase …

  当胰岛素与其受体酪氨酸激酶结合后，随后发生的事件是 …

• this antibody may cross-react with other activated receptor tyrosine kinases.

  本抗体可能与其它酪氨酸位点被磷酸化的激活受体发生交叉反应。

• objective:to explore the mutation of receptor tyrosine kinase ( ret ) gene in sporadic medullary thyroid carcinoma.

  目的：研究散发型甲状腺髓样癌酪氨酸激酶受体基因（ret）的突变情况。

• in this paper, the quantity of insulin receptors and the receptor tyrosine kinase activity and its endogenous substrates were comparatively studied in k-562 cells before and after transformation.

  对丁酸钠转化前后的人红白血病细胞林k-562的表面胰岛素受体数量、胰岛素受体酪氨酸蛋白激酶活性及细胞内源性底物进行了研究。

• receptor tyrosine protein kinase is one of key kinases in cell signal transduction and plays an important role in the process of cell growth, development and functions regulated by growth factors.

  受体酪氨酸蛋白激酶是细胞信号转导进行的关键信号酶，在生长因子调控细胞生长、发育与功能的过程中起着重要的生理作用。

• the tyrosine phosphorylated 130000 protein was identified as jak2, a non receptor tyrosine kinase.

  鑒定了分子量为130000酪氨酸磷酸化的蛋白质为jak2，一种非受体型酪氨酸激酶。

• the inhibitor of vegf receptor tyrosine kinase was introduced in detail.

  详细介绍了vegf受体酪氨酸激酶抑制剂的研究进展。

• in this perspective, we focus on recent work in which the fret approach has been applied to study cell signaling of receptor tyrosine kinases.

  本文中我们以受体酪氨酸激酶为例，介绍fret技术在受体介导细胞信号传导中的应用及进展情况。